ALMR
Alamar Biosciences, Inc. Common Stock
NASDAQ: ALMR · HEALTHCARE · MEDICAL DEVICES
$25.04
+2.29% today
Updated 2026-04-30
Market cap
$1.67B
P/E ratio
—
P/S ratio
22.50x
EPS (TTM)
$-0.45
Dividend yield
—
52W range
$17 – $27
Volume
0.9M
WallStSmart proprietary scores
16
out of 100
Grade: F
Strong Sell
Investment rating
6.0
Growth
B5.0
Quality
C+2.0
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at -40.20%
- Negative free cash flow $-59.99M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2024 | 2025 | TTM |
|---|---|---|---|
| Revenue | $25.14M | $74.21M | $74.21M |
| Net income | $-47.07M | $-29.82M | $-29.82M |
| EPS | — | — | $-0.45 |
| Free cash flow | $-58.60M | $-59.99M | $-59.99M |
| Profit margin | -187.23% | -40.18% | -40.20% |
Peer comparison
Smart narrative
Alamar Biosciences, Inc. Common Stock trades at $25.04. Our Smart Value Score of 16/100 indicates the stock is weak. TTM revenue stands at $74.21M. with profit margins at -40.20%.
Frequently asked questions
What is Alamar Biosciences, Inc. Common Stock's stock price?
Alamar Biosciences, Inc. Common Stock (ALMR) trades at $25.04.
Is Alamar Biosciences, Inc. Common Stock overvalued?
Smart Value Score 16/100 (Grade F, Strong Sell).
What is the price target of Alamar Biosciences, Inc. Common Stock (ALMR)?
The analyst target price is $—, representing NaN% downside from the current price of $25.04.
What is Alamar Biosciences, Inc. Common Stock's revenue?
TTM revenue is $74.21M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio22.50x
ROE-33.60%
Beta—
50D MA$24.21
200D MA$24.21
Shares out0.07B
Float0.01B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—